Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioVaxys Technology Corp.
C.BIOV
Alternate Symbol(s):
BVAXF
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical...
-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:BIOV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Sep 07, 2021 4:37pm
Biovaxys
https://m.youtube.com/watch?v=S7azFqnMeBo
(66)
•••
Humanist
X
View Profile
View Bullboard History
Comment by
Humanist
on Sep 07, 2021 10:31am
RE:Biovaxys technology update
heres the article ......................lots of good info Further Study in humans shows that the DTH response, the basis for CoviDTH, is highly durable and persists for at least one year after COVID
...more
Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study
posted Jun 13, 2024 9:00am by
Revive Therapeutics Ltd.
-
|
“We are pleased with the FDA’s recommendations for our proposed clinical study, which provides a pathway for the clinical development of Bucillamine as a potential treatment for Long COVID,” said Michael Frank, CEO of Revive. “We aim to finalize the clinical study protocol and submit a new IND, which will cross reference our current IND to obtain FDA approval to proceed with the clinical trial for Long COVID.” ...read more
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Sep 07, 2021 8:12am
Biovaxys technology update
https://www.prnewswire.com/news-releases/further-study-in-humans-shows-that-the-dth-response-the-basis-for-covidth-is-highly-durable-and-persists-for-at-least-one-year-after-covid-19-exposure-or
...more
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Sep 06, 2021 6:39pm
Biovaxys technology
https://soundcloud.com/rxradiofm/episode-118-inventing-a-vaccine-a-conversation-with-the-chief-medical-officer-of-biovaxys
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Sep 05, 2021 12:17am
Stock market value
https://twitter.com/danyal54794544/status/1434325581106073602?s=21
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Sep 05, 2021 12:11am
Stock market
https://twitter.com/alex50146872/status/1434299844454141962?s=12
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Sep 04, 2021 11:45pm
Stock market
https://twitter.com/danyal54794544/status/1434338176798101504?s=21
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Sep 04, 2021 9:42pm
Best Stocks Under 50 Cents, Stocks For 50 Cents.
Best Stocks Under 50 Cents, Stocks For 50 Cents. https://walletinvestor.com/stock-forecast/stocks-under-50-cents?page=6&per-page=100
(66)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Sep 03, 2021 2:39pm
SOMETHING MUST BE COMING & SOMEONE KNOWS IT !UP 40% & 2..5 V
UP 40% & VOLUME 2.5 TIMES THE AVG ... I HOPE I AM RIGHT:) HAVE A GLTA & GOOD WEEKEND!
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Aug 31, 2021 1:14pm
World vaccine
https://www.terrapinn.com/conference/world-vaccine-immunotherapy-congress-west-coast/speaker-drdavid-BERD.stm
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Aug 22, 2021 4:43am
Biovaxys technology
https://www.youtube.com/watch?v=JEf-Ad1C0TA
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Aug 21, 2021 1:15am
Biovaxys technology
https://dnapodcast.com/episodes/2021/8/20/154-kenneth-kovan-amp-david-berd-on-haptenized-vaccines
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Aug 18, 2021 7:57pm
HPV Vaccine News 2021
https://www.precisionvaccinations.com/vaccines/hpv-vaccines
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Aug 16, 2021 10:37pm
Biovaxys technology
https://beststartup.us/101-top-new-york-city-biotechnology-companies-and-startups-of-2021/
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
AirBoss of America Corp. Class Action Certification and Settlement
The Convenience of Modern Banking With the Benefits of Bitcoin Has Arrived
A Junior Copper-Gold Stock Trading at a Bargain of Monumental Proportions
Xcyte Digital Corp. Announces Execution of Definitive Agreement with MCON Live Inc.
Flow Rate and Helium Concentration Confirms Topaz Project as World-Class Helium Well